We are live on ! Find out more
Muhlenkamp & Co

Muhlenkamp & Co Portfolio holdings

AUM $411M Turnover 18.18%
1-Year Est. Return 32.57%
This Fund
S&P 500
This Quarter Est. Return
+6.56%
1 Year Est. Return
+32.57%
3 Year Est. Return
+127.88%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$8.72M
Cap. Flow
-$3.69M
Cap. Flow %
-1.39%
Top 10 Hldgs %
52.32%
Holding
59
New
5
Increased
9
Reduced
28
Closed
3
Avg Time Held Equity + Options
1.7 years
Top 10 Avg Time Held Equity + Options
1.1 years
Top 20 Avg Time Held Equity + Options
1.1 years
Avg Time Held Equity only
1.9 years
Top 10 Avg Time Held Equity only
1.1 years
Top 20 Avg Time Held Equity only
1.2 years

Top Buys

Rank Stock Value
1
CELG
Celgene
CELG
+$5.81M
2
WCIC
WCI Communities
WCIC
+$881K
3
MS icon
Morgan Stanley
MS
+$194K
4
AFMD icon
Affimed
AFMD
+$123K
5
ALGT icon
Allegiant Air
ALGT
+$34.9K

Sector Composition

Rank Sector Weight
1 Healthcare 30.1%
2 Technology 18.94%
3 Consumer Discretionary 12.06%
4 Financials 9.99%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BFH icon
1
Bread Financial
BFH
$3.5B
$25.8M 9.74%
150,648
-782
-0.5% -$133K
2013 Q2
13 quarters
GILD icon
2
Gilead Sciences
GILD
$206B
$17M 6.41%
214,495
-2,505
-1% -$203K
2013 Q2
13 quarters
AAPL icon
3
Apple
AAPL
$4.98T
$17M 6.41%
600,444
-2,076
-0.3% -$54.9K
2013 Q2
13 quarters
ON icon
4
ON Semiconductor
ON
$23.7B
$15.5M 5.84%
1,255,265
-6,470
-0.5% -$66.9K
2014 Q3
8 quarters
MSFT icon
5
Microsoft
MSFT
$3.6T
$13.5M 5.11%
234,738
-800
-0.3% -$45.2K
2013 Q2
13 quarters
GLD icon
6
SPDR Gold Trust
GLD
$118B
$10.9M 4.12%
86,715
-605
-0.7% -$77.1K
2016 Q2
1 quarter
HBI icon
7
DELISTED
Hanesbrands
HBI
$10M 3.78%
396,705
-2,450
-0.6% -$64.6K
2013 Q2
13 quarters
WCIC
8
DELISTED
WCI Communities
WCIC
$9.7M 3.68%
410,495
+47,825
+13% +$881K
2013 Q3
12 quarters
BMY icon
9
Bristol-Myers Squibb
BMY
$120B
$9.7M 3.67%
180,316
-1,024
-0.6% -$65.8K
2014 Q1
10 quarters
RUSHA icon
10
Rush Enterprises Class A
RUSHA
$5.09B
$9.42M 3.56%
1,299,382
– –
2013 Q2
13 quarters
UNH icon
11
UnitedHealth
UNH
$305B
$8.35M 3.15%
59,660
-560
-0.9% -$78.4K
2016 Q1
2 quarters
CE icon
12
Celanese
CE
$4.94B
$8.24M 3.11%
123,720
-850
-0.7% -$55.6K
2014 Q4
7 quarters
SAVE icon
13
DELISTED
Spirit Airlines
SAVE
$8.14M 3.07%
191,280
-1,275
-0.7% -$52.9K
2013 Q2
13 quarters
TEVA icon
14
Teva Pharmaceutical Industries
TEVA
$45.8B
$8.09M 3.05%
175,770
-885
-0.5% -$46.2K
2013 Q2
13 quarters
CELG
15
DELISTED
Celgene
CELG
$7.68M 2.9%
73,515
+53,706
+271% +$5.81M
2016 Q2
1 quarter
MCK icon
16
McKesson
MCK
$123B
$7.63M 2.88%
45,753
-430
-0.9% -$80.2K
2016 Q2
1 quarter
BIIB icon
17
Biogen
BIIB
$36.9B
$7.35M 2.78%
23,478
-225
-0.9% -$66.6K
2016 Q1
2 quarters
LCI
18
DELISTED
Lannett
LCI
$7.2M 2.72%
67,733
-33,368
-33% -$4.08M
2016 Q1
2 quarters
DAL icon
19
Delta Air Lines
DAL
$52.6B
$5.27M 1.99%
134,005
+300
+0.2% +$11.4K
2013 Q2
13 quarters
GMLP
20
DELISTED
Golar LNG Partners
GMLP
$5.19M 1.96%
264,295
-1,110
-0.4% -$21K
2016 Q1
2 quarters
SLB icon
21
SLB
SLB
$67.7B
$4.72M 1.78%
59,985
-95
-0.2% -$7.54K
2015 Q3
4 quarters
ALGT icon
22
Allegiant Air
ALGT
$2.49B
$4.52M 1.71%
34,258
+257
+0.8% +$34.9K
2013 Q2
13 quarters
HAL icon
23
Halliburton
HAL
$25.3B
$4.49M 1.7%
100,000
– –
2013 Q2
13 quarters
CYH icon
24
Community Health Systems
CYH
$228M
$4.33M 1.64%
375,380
-1,865
-0.5% -$21.5K
2016 Q2
1 quarter
OLED icon
25
Universal Display
OLED
$3.49B
$4.18M 1.58%
75,360
+430
+0.6% +$27.3K
2013 Q2
13 quarters

Similar funds

Muhlenkamp & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Muhlenkamp & Co held 59 positions worth $265M, up 3.4% from $256M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Muhlenkamp & Co's Q3 2016 filing shows 5 new, 9 increased, 28 reduced and 3 closed positions. Its largest new stake was Morgan Stanley: 6,505 shares worth $209K. The largest sale was Neustar, an estimated $7.23M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Muhlenkamp & Co's largest Q3 2016 buy was Morgan Stanley: 6,505 shares worth $209K.
  • Muhlenkamp & Co added most to Celgene in Q3 2016, an estimated $5.81M increase.
  • Muhlenkamp & Co's biggest Q3 2016 reduction was Invesco BuyBack Achievers ETF, cutting an estimated $4.76M.
  • Muhlenkamp & Co fully exited Neustar in Q3 2016, selling an estimated $7.23M.
  • Muhlenkamp & Co's ten largest holdings make up 52% of its $265M portfolio in Q3 2016.
  • Muhlenkamp & Co opened 5 new positions and closed 3 in Q3 2016.
  • Muhlenkamp & Co's portfolio value rose 3.4% quarter-over-quarter to $265M.

Based on Muhlenkamp & Co's 13F filing for Q3 2016, filed 14 Nov 2016.